Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms

Published:2014-04-24 Issue:17 Volume:123 Page:2645-2651
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Wang Sa A.¹,Hasserjian Robert P.²,Fox Patricia S.³,Rogers Heesun J.⁴,Geyer Julia T.⁵,Chabot-Richards Devon⁶^ORCID,Weinzierl Elizabeth⁷,Hatem Joseph⁸,Jaso Jesse¹,Kanagal-Shamanna Rashmi¹,Stingo Francesco C.³,Patel Keyur P.¹,Mehrotra Meenakshi¹,Bueso-Ramos Carlos¹,Young Ken H.¹,Dinardo Courtney D.⁹,Verstovsek Srdan⁹,Tiu Ramon V.¹⁰,Bagg Adam⁸,Hsi Eric D.⁴,Arber Daniel A.⁷,Foucar Kathryn⁶,Luthra Raja¹,Orazi Attilio⁵

Affiliation:

1. Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX;

2. Department of Pathology, Massachusetts General Hospital, Boston, MA;

3. Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX;

4. Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH;

5. Department of Pathology, Weill Cornell Medical College, New York, NY;

6. Department of Pathology, University of New Mexico, Albuquerque, NM;

7. Department of Pathology, Stanford University, Stanford, CA;

8. Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA;

9. Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX; and

10. Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Foundation, Cleveland, OH

Abstract

Key Points Within MDS/MPN, the WHO 2008 criteria for aCML identify a subgroup of patients with aggressive clinical features distinct from MDS/MPN-U. The MDS/MPN-U category is heterogeneous, and patient risk can be further stratified by a number of clinicopathological parameters.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/123/17/2645/1375870/2645.pdf

Reference36 articles.

1. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.;Vardiman;Blood,2009

2. Haematological differences between chronic granulocytic leukaemia, atypical chronic myeloid leukaemia, and chronic myelomonocytic leukaemia.;Galton;Leuk Lymphoma,1992

3. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia.;Bennett;Br J Haematol,1994

4. Identification of risk factors in atypical chronic myeloid leukemia.;Breccia;Haematologica,2006

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Juvenile Myelomonocytic Leukemia (JMML);Pediatric Pathology of Hematopoietic and Histiocytic Disorders;2024-02-15

2. Characteristics, primary treatment, and survival of MDS/MPN with neutrophilia: a population-based study;Blood Advances;2023-12-15

3. Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape;International Journal of Molecular Sciences;2023-12-12

4. Atypical CML: diagnosis and treatment;Hematology;2023-12-08

5. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10